Uğur Önal

Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey

Mine Durusu Tanrıöver, Levent Doğanay, Murat Akova et al. · The Lancet · 2021 · 929 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +13

Synergistic antibacterial activity of ceftazidime–avibactam in combination with colistin, gentamicin, amikacin, and fosfomycin against carbapenem-resistant Klebsiella pneumoniae

Nazmiye Ülkü Tüzemen, Uğur Önal, Osman Merdan et al. · Scientific Reports · 2024 · 19 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Development and validation of a modified quick SOFA scale for risk assessment in sepsis syndrome

Yasemin Çağ, Oğuz Karabay, Oğuz Reşat Sıpahı et al. · PLoS ONE · 2018 · 16 citations · Full text

Veterinary Medicine, Emergency Medicine, Internal Medicine +16

An outbreak of Ralstonia insidiosa bloodstream infections caused by contaminated heparinized syringes

Nazmiye Ülkü Tüzemen, Uğur Önal, Esra Kazak et al. · Journal of Infection and Chemotherapy · 2022 · 13 citations

Life Sciences, Infectious Diseases, Microbiology +14

Multicenter evaluation of ceftazidime-avibactam use in carbapenem-resistant Klebsiella pneumoniae bloodstream infections in OXA-48 endemic regions

Ali Mert, Okan Derin, Halis Akalın et al. · Scientific Reports · 2024 · 13 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +14